Società Delta 9 Cannabis Inc Toronto S.E.
Azioni
CA2477541049
Prodotti farmaceutici
Attività
Vendite per attività
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Retail Cannabis and Merchandise and Devices
86,1
%
| 52 | 82,8 % | 61 | 86,1 % | +16,92% |
Wholesale Cannabis
11,4
%
| 9 | 14,1 % | 8 | 11,4 % | -8,74% |
Business to Business
2,4
%
| 2 | 3,1 % | 2 | 2,4 % | -12,39% |
Vendite per regione
CAD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 63 | 100,0 % | 71 | 100,0 % | +12,39% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/01/12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Mark Jonker
COO | Chief Operating Officer | - | 01/08/19 |
John Arbuthnot
BRD | Director/Board Member | 70 | 01/01/12 |
Ian Chadsey
IRC | Investor Relations Contact | - | 01/01/19 |
Kelsey Friesen
SAM | Sales & Marketing | - | - |
Marshall Posner
SAM | Sales & Marketing | - | - |
David Kideckel
PRN | Corporate Officer/Principal | - | 16/08/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07/09/18 |
Nitin Kaushal
CHM | Chairman | 58 | 31/10/17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01/01/12 |
John Arbuthnot
BRD | Director/Board Member | 70 | 01/01/12 |
Stuart Starkey
BRD | Director/Board Member | - | 19/12/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 296 177 103 | 219 483 528 ( 74,11 %) | 0 | 74,11 % |
Coordinate società
Settore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
+38,59% | 727 Mrd | |
-7,89% | 347 Mrd | |
+15,66% | 319 Mrd | |
+0,24% | 274 Mrd | |
+12,85% | 238 Mrd | |
+7,00% | 204 Mrd | |
-6,46% | 203 Mrd | |
+4,23% | 161 Mrd | |
-1,70% | 160 Mrd |